Table of Contents

Table of Contents

List of Tables

List of Figures

Epinex Diagnostics Inc Company Overview

Epinex Diagnostics Inc Company Snapshot

Epinex Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview

Epinex Diagnostics Inc – Pipeline Analysis Overview

Epinex Diagnostics Inc - Key Facts

Epinex Diagnostics Inc - Major Products and Services

Epinex Diagnostics Inc Pipeline Products by Development Stage

Epinex Diagnostics Inc Pipeline Products Overview

Down Syndrome Screen Test

Down Syndrome Screen Test Product Overview

Epinex ACR Albumin/Creatinine Ratio Test

Epinex ACR Albumin/Creatinine Ratio Test Product Overview

Epinex G1A - Coronary Artery Disease Rapid Diagnostic Test

Epinex G1A - Coronary Artery Disease Rapid Diagnostic Test Product Overview

Epinex G1A - Infectious Disease Rapid Diagnostic Test

Epinex G1A - Infectious Disease Rapid Diagnostic Test Product Overview

Epinex G1A - Neo-natal HIV Test

Epinex G1A - Neo-natal HIV Test Product Overview

Epinex G1A - Pre-Diabetes and Metabolic Syndrome Rapid ScreeningTest

Epinex G1A - Pre-Diabetes and Metabolic Syndrome Rapid ScreeningTest Product Overview

Epinex G1A - Rheumatoid Arthritis Rapid Diagnostic Test

Epinex G1A - Rheumatoid Arthritis Rapid Diagnostic Test Product Overview

Epinex G1A - Type 2 Diabetes Test

Epinex G1A - Type 2 Diabetes Test Product Overview

Epinex G1A OTC Device

Epinex G1A OTC Device Product Overview

Epinex G1A POC Device

Epinex G1A POC Device Product Overview

Epinex Diagnostics Inc - Key Competitors

Epinex Diagnostics Inc - Key Employees

Epinex Diagnostics Inc - Locations And Subsidiaries

Head Office

Recent Developments

Epinex Diagnostics Inc, Recent Developments

Sep 10, 2012: Epinex Receives Canadian Patent For Epinex G1A Rapid Diabetes Monitoring Index Test

Feb 21, 2012: Epinex Receives Patent In Hong Kong For G1A Test

Jun 14, 2011: Epinex' G1A Rapid Diabetes Monitoring Index Test Receives European Patent

Apr 06, 2011: UPDATE: Glycated Albumin Presented as a Novel Biomarker For Diabetes Monitoring

Mar 08, 2011: Glycated Albumin Presented As Novel Biomarker For Diabetes Monitoring: Epinex

Nov 08, 2010: Epinex Diagnostics Receives Government Grant For G1A Diabetes Test

Oct 20, 2010: Syprosoft Engineering Develops First Prototype G1A Reader For Epinex Diagnostics

Mar 02, 2010: Epinex Receives US Patent For G1A Rapid Diabetes Monitoring Index Test

Oct 31, 2006: Epinex Develops Prototype For Monthly Type 2 Diabetes Test

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer

Summary

Epinex Diagnostics Inc (Epinex Diagnostics) is a developer of rapid diagnostic test solutions.Its product portfolio includes over-the-counter test device, Epinex G1A Test system, Epinex ACR Test system, Epinex SimplySure PT-INR Test system and point-of-care test device. Its Epinex G1A system is rapid diabetes monitoring index test for the control of glycation. Epinex Diagnostics offers tests for infectious diseases, coronary artery disease, rheumatoid arthritis, metabolic disorders, Down’s syndrome, and neonatal HIV, among others. The company operates through outpatient care centers, community and corporate wellness programs, and clinics for rapid diagnostic testing. Epinex Diagnostics is headquartered in Tustin, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Epinex Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company